RESEARCH AND DEVELOPMENT

Current Clinical Trial Development

Matrix Biomed, Inc. is currently developing seven compounds and has identified TEMPOL, formally 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl, as the lead compound.

computer-screen-20-v5-centered

According to the Centers for Disease Control (CDC),  about 650,000 cancer patients receive chemotherapy annually. Each of these patients will experience toxic side effects due to chemotherapy.

PREVENTION OF TOXICITIES INDUCED BY RADIATION
PREVENTION OF TOXICITIES INDUCED BY RADIATION
MBI-06-01
Toxicities associated with radiation treatment include dermatitis (inflammation of the skin), depression, fatigue, erectile dysfunction, cardiovascular disease, mucositis (oral ulceration/inability to swallow), infertility, enteritis (inflammation of the intestine), pneumonitis (inflammation of the lung), secondary malignancy (cancer), and many more. Matrix Biomed, Inc. is focused on improving patient quality of life by making radiation therapy better tolerated.
PREVENTION OF TOXICITIES INDUCED BY PLATINUM-BASED AGENTS
PREVENTION OF TOXICITIES INDUCED BY PLATINUM-BASED AGENTS
MBI-04-04
Toxicities associated with platinum-based agents, such as cisplatin, include mucositis (oral ulceration/inability to swallow), nephrotoxicity (kidney damage), myelosuppression (low blood cell count), ototoxicity (hearing loss), nausea, vomiting, alopecia (hair loss), secondary malignancy (cancer), and many more. Matrix Biomed, Inc. is focused on improving patient quality of life by making cisplatin treatments better tolerated.
PREVENTION OF TOXICITIES INDUCED BY TAXANES
PREVENTION OF TOXICITIES INDUCED BY TAXANES
MBI-08-01
Toxicities associated with taxanes, such as paclitaxel, include myelosuppression (low blood cell count), myalgia (muscle soreness), arthralgia (joint pain), neuropathy (nerve damage), mouth sores, hypersensitivity, nausea, vomiting, alopecia (hair loss), secondary malignancy (cancer), and many more. Matrix Biomed, Inc. is focused on improving patient quality of life by making paclitaxel treatments better tolerated.
PREVENTION OF TOXICITIES INDUCED BY ANTHRACYCLINES
PREVENTION OF TOXICITIES INDUCED BY ANTHRACYCLINES
MBI-05-01
Toxicities associated with anthracyclines, such as doxorubicin, include neutropenia (low neutrophil count), anemia (low red blood cells), leukopenia (low white blood cells), pruritus (itchy skin), stomatitis (mouth inflammation), thrombocytopenia (low platelets), cardiotoxicity (damage to the heart), myelosuppression (low blood cell count), reduction in brain function and size, alopecia (hair loss), secondary malignancy (cancer), and many more. Matrix Biomed, Inc. is focused on improving patient quality of life by making doxorubicin treatments better tolerated.
TREATMENT AND PREVENTION OF AGE-RELATED EYE DISEASES
TREATMENT AND PREVENTION OF AGE-RELATED EYE DISEASES
MBI-07-01
Glaucoma, macular degeneration, diabetic retinopathy, and cataracts are age-related eye diseases that account for severe vision impairment and substantial decreases in quality of life for one out of every three people in the United States over the age of 65. Matrix Biomed, Inc. is focused on developing therapies for age-related eye diseases.
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt